These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25868977)

  • 1. Triple negative breast cancers comprise a highly tumorigenic cell subpopulation detectable by its high responsiveness to a Sox2 regulatory region 2 (SRR2) reporter.
    Jung K; Gupta N; Wang P; Lewis JT; Gopal K; Wu F; Ye X; Alshareef A; Abdulkarim BS; Douglas DN; Kneteman NM; Lai R
    Oncotarget; 2015 Apr; 6(12):10366-73. PubMed ID: 25868977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress induces the acquisition of cancer stem-like phenotype in breast cancer detectable by using a Sox2 regulatory region-2 (SRR2) reporter.
    Gopal K; Gupta N; Zhang H; Alshareef A; Alqahtani H; Bigras G; Lewis J; Douglas D; Kneteman N; Lavasanifar A; Lai R
    Oncotarget; 2016 Jan; 7(3):3111-27. PubMed ID: 26683522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer.
    Gupta N; Jung K; Wu C; Alshareef A; Alqahtani H; Damaraju S; Mackey JR; Ghosh S; Sabri S; Abdulkarim BS; Bigras G; Lai R
    Oncotarget; 2017 Apr; 8(17):28101-28115. PubMed ID: 28427212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A positive feedback loop involving the Wnt/β-catenin/MYC/Sox2 axis defines a highly tumorigenic cell subpopulation in ALK-positive anaplastic large cell lymphoma.
    Wu C; Zhang HF; Gupta N; Alshareef A; Wang Q; Huang YH; Lewis JT; Douglas DN; Kneteman NM; Lai R
    J Hematol Oncol; 2016 Nov; 9(1):120. PubMed ID: 27821172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDX17 (P72), a Sox2 binding partner, promotes stem-like features conferred by Sox2 in a small cell population in estrogen receptor-positive breast cancer.
    Alqahtani H; Gopal K; Gupta N; Jung K; Alshareef A; Ye X; Wu F; Li L; Lai R
    Cell Signal; 2016 Feb; 28(2):42-50. PubMed ID: 26569340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enriched CD44(+)/CD24(-) population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC).
    Ma F; Li H; Wang H; Shi X; Fan Y; Ding X; Lin C; Zhan Q; Qian H; Xu B
    Cancer Lett; 2014 Oct; 353(2):153-9. PubMed ID: 25130168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in γ-secretase inhibitor drug responses.
    Azzam DJ; Zhao D; Sun J; Minn AJ; Ranganathan P; Drews-Elger K; Han X; Picon-Ruiz M; Gilbert CA; Wander SA; Capobianco AJ; El-Ashry D; Slingerland JM
    EMBO Mol Med; 2013 Oct; 5(10):1502-22. PubMed ID: 23982961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.
    Thiagarajan PS; Hitomi M; Hale JS; Alvarado AG; Otvos B; Sinyuk M; Stoltz K; Wiechert A; Mulkearns-Hubert E; Jarrar A; Zheng Q; Thomas D; Egelhoff T; Rich JN; Liu H; Lathia JD; Reizes O
    Stem Cells; 2015 Jul; 33(7):2114-2125. PubMed ID: 25827713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of Sox2 at Threonine 116 is a Potential Marker to Identify a Subset of Breast Cancer Cells with High Tumorigenecity and Stem-Like Features.
    Gupta N; Gopal K; Wu C; Alshareef A; Chow A; Wu F; Wang P; Ye X; Bigras G; Lai R
    Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29401647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells.
    Jung K; Wu F; Wang P; Ye X; Abdulkarim BS; Lai R
    BMC Cancer; 2014 May; 14():328. PubMed ID: 24885403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays.
    Jung K; Wang P; Gupta N; Gopal K; Wu F; Ye X; Alshareef A; Bigras G; McMullen TP; Abdulkarim BS; Lai R
    Breast Cancer Res; 2014 Nov; 16(6):470. PubMed ID: 25380620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress enhances tumorigenicity and stem-like features via the activation of the Wnt/β-catenin/MYC/Sox2 axis in ALK-positive anaplastic large-cell lymphoma.
    Wu C; Gupta N; Huang YH; Zhang HF; Alshareef A; Chow A; Lai R
    BMC Cancer; 2018 Apr; 18(1):361. PubMed ID: 29609590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Catenin, a Sox2 binding partner, regulates the DNA binding and transcriptional activity of Sox2 in breast cancer cells.
    Ye X; Wu F; Wu C; Wang P; Jung K; Gopal K; Ma Y; Li L; Lai R
    Cell Signal; 2014 Mar; 26(3):492-501. PubMed ID: 24291232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIX2 Mediates Late-Stage Metastasis via Direct Regulation of
    Oliphant MUJ; Vincent MY; Galbraith MD; Pandey A; Zaberezhnyy V; Rudra P; Johnson KR; Costello JC; Ghosh D; DeGregori J; Espinosa JM; Ford HL
    Cancer Res; 2019 Feb; 79(4):720-734. PubMed ID: 30606720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer.
    Liu M; Liu Y; Deng L; Wang D; He X; Zhou L; Wicha MS; Bai F; Liu S
    Mol Cancer; 2018 Feb; 17(1):65. PubMed ID: 29471829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PI3K/AKT/c-MYC Axis Promotes the Acquisition of Cancer Stem-Like Features in Esophageal Squamous Cell Carcinoma.
    Zhang HF; Wu C; Alshareef A; Gupta N; Zhao Q; Xu XE; Jiao JW; Li EM; Xu LY; Lai R
    Stem Cells; 2016 Aug; 34(8):2040-51. PubMed ID: 27144349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cancer stem cell markers in basal and penta-negative breast carcinomas--a study of a series of triple-negative tumors.
    Uchôa Dde M; Graudenz MS; Callegari-Jacques SM; Hartmann CR; Ferreira BP; Fitarelli-Kiehl M; Edelweiss MI
    Pathol Res Pract; 2014 Jul; 210(7):432-9. PubMed ID: 24726267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.
    Zheng Z; Shao N; Weng H; Li W; Zhang J; Zhang L; Yang L; Ye S
    Med Oncol; 2015 Jan; 32(1):275. PubMed ID: 25429827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.